is a regenerative medicine company focused on lung diseases using our licensed and patented umbilical cord derived mesenchymal stem cell, termed “JadiCell™”
COPD is a consistently progressive, ultimately fatal disease.
million Americans (6.4%) reported that they have been diagnosed with COPD
of adults with low pulmonary function were not aware that they had COPD
million deaths worldwide in 2019. COPD is the third leading cause of death worldwide
of COPD deaths in those under 70 years of age occur in low- and middle-income countries
leading cause of poor health worldwide is COPD
of COPD is smoking related in high-income countries
JadiCell Therapy for COPD IND # 28508
safety and efficacy of intravenously administered allogeneic JadiCell umbilical cord blood mesenchymal stem cells in patients with moderate-to-severe COPD.